Gut bacteria produce substances that lower blood pressure and heart disease risk Genetic mutations can block the protective ...

On the 17 th of June 2025, Mr Kevin Assoumou will defend his PhD thesis entitled "Regulation of GPCR anterograde trafficking". His thesis was conducted under the direction of Pre Miriam Stoeber from ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting pre-clinical data on DA-1241, a ...

The subcellular signaling landscape of receptors. G protein-coupled receptors (GPCRs) form the largest receptor family in humans. GPCRs mediate the effects of diverse natural liga ...

Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for ch ...

Nxera Pharma has announced a significant development milestone in its multi-target collaboration with Eli Lilly, marking a ...

“The study found that disruption in these receptors is associated with up to 20 per cent increased prevalence of hypertension and heart disease or stroke – even after accounting for other risk factors ...

Engineering of TRPM8 channel to be activated by CHXOL and more sensitive to CHXOL.  FAYETTEVILLE, GA, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- In a breakthrough advancement for neuroscience, ...

Recent breakthroughs in understanding the prostaglandin D2 (PGD2) receptor 1 (DP1) are paving the way for innovative ...

Researchers have captured a time-resolved video of a protein interaction essential to healthy brain development.

Recent breakthroughs in understanding the prostaglandin D2 (PGD2) receptor 1 (DP1) are paving the way for innovative anti-inflammatory and ...